10x Genomics, Inc. — Director's Dealing 2020

Mar 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-03-06

Reporting Person: Saxonov Serge (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-06	Class A Common Stock	M	8333	$1.07	Acquired	946347	Direct
2020-03-06	Class A Common Stock	M	1667	$1.20	Acquired	948014	Direct
2020-03-06	Class A Common Stock	S	1848	$62.9126	Disposed	946166	Direct
2020-03-06	Class A Common Stock	S	3767	$63.9132	Disposed	942399	Direct
2020-03-06	Class A Common Stock	S	1098	$64.9121	Disposed	941301	Direct
2020-03-06	Class A Common Stock	S	800	$65.785	Disposed	940501	Direct
2020-03-06	Class A Common Stock	S	600	$66.86	Disposed	939901	Direct
2020-03-06	Class A Common Stock	S	618	$68.1285	Disposed	939283	Direct
2020-03-06	Class A Common Stock	S	822	$69.3429	Disposed	938461	Direct
2020-03-06	Class A Common Stock	S	447	$70.0057	Disposed	938014	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-06	Stock Option (right to buy)	$1.07	M	8333	Disposed	2026-11-18	Class A Common Stock (8333)	Direct
2020-03-06	Stock Option (right to buy)	$1.20	M	1667	Disposed	2027-10-18	Class A Common Stock (1667)	Direct

Footnotes

F1: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $62.39 to $63.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $63.405 to $64.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $64.40 to $65.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $65.51 to $66.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $66.65 to $67.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $67.69 to $68.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: This transaction was executed in multiple trades at prices ranging from $68.70 to $69.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F9: This transaction was executed in multiple trades at prices ranging from $69.78 to $70.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F10: This option, originally for 200,000 shares, of which 166,666 have been exercised, vested as to one-fourth of the shares on August 1, 2017, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F11: This option, originally for 300,000 shares, of which 157,917 have been exercised, vested as to one-fourth of the shares on October 1, 2017, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.